SCHEMBL19086572

SCHEMBL19086572

COC(=O)c1c(O)c2cc(S(=O)(=O)Cl)ccc2n(C)c1=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.46
ALDH1A1 P00352 4/20 0.45
KDM4E B2RXH2 4/20 0.45
HIF1A Q16665 3/20 0.45
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
GSK3B P49841 2/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
USP2 O75604 1/20 0.40
TSHR P16473 1/20 0.40
LMNA P02545 2/20 0.39
HPGD P15428 1/20 0.39
RECQL P46063 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19086606 0.80 ALDH1A1 (0.57) ALDH1A1KDM4EHIF1AMEN1KMT2A
SCHEMBL19086602 0.79 HIF1A (0.73) ALDH1A1KDM4EHIF1AMEN1KMT2A
SCHEMBL28211944 0.78 PIK3CG (0.43) RXFP1ALDH1A1KDM4EHIF1AKMT2A
SCHEMBL28825729 0.78 KDM4E (0.43) RXFP1ALDH1A1KDM4EHIF1AMEN1
SCHEMBL1685954 0.76 ALDH1A1 (0.72) ALDH1A1KDM4EMEN1KMT2ANPC1
SCHEMBL19086664 0.75 HIF1A (0.71) ALDH1A1KDM4EHIF1AGAA
SCHEMBL19086548 0.73 HIF1A (0.71) ALDH1A1KDM4EHIF1AGAA
SCHEMBL2436234 0.72 ALDH1A1 (0.41) ALDH1A1KDM4EHIF1AMEN1KMT2A
SCHEMBL19086870 0.72 NPC1 (0.53) ALDH1A1KDM4EHIF1AMEN1KMT2A
SCHEMBL26204452 0.72 ELANE (0.43) RXFP1ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3190104-B1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO LTD (CN) 2021-10-27 EP disclosed
US-10065928-B2 Quinolinone compound and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2018-09-04 US disclosed
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2017-08-31 US disclosed
EP-3190104-A1 QUINOLINONE COMPOUND AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2017-07-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170247332-A1 QUINOLINONE COMPOUND AND USE THEREOF HIF1AN, HIF1A, EGLN2 RXFP1 518/4885ALDH1A1 517/4885KDM4E 729/4885
US-10065928-B2 Quinolinone compound and use thereof HIF1AN, HIF1A, EGLN2 RXFP1 518/4885ALDH1A1 517/4885KDM4E 729/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.